56691

Insurtech deals on the up, but total funding drops

Willis Towers Watson ascribes funding drop to fewer “high dollar” transactions

56671

Activist ups pressure on Scor over Covea deal

Scor still rejects approach by largest shareholder

56661

Vaudoise bucks European trend and posts non-life profits

Swiss group non-life premiums by 3.8% in the first half of the year

56621

Finding the goal in insurtech - part one: the investors

Strategies for capitalising on new insurance technologies are as varied as the technologies themselves. In part one of this series of interviews, Cintia Cheong talks to insurtech investors about the most promising areas for tech development, and how they are making their investments

56571

Still room for SFCR improvement, BaFin tells industry

German regulator says improvements are evident in second year of reporting, though

56581

Marsh & McLennan swoops for JLT

The mega deal will combine two of the largest insurance and reinsurance broking groups

56551

Chinese insurers' C-Ross compliance pays off

But firms are still exposed to risky investments

56521

AMP took life premiums from dead customers, Royal Commission hears

Inquiry had summoned Australian insurer for a second time

56491

Australian health industry gets new prudential standards

Regulator issues rules on governance, board membership and audit

56471

China Re to acquire speciality insurer Chaucer

The Hanover sells out in $950m deal